1. Home
  2. IXHL vs INCR Comparison

IXHL vs INCR Comparison

Compare IXHL & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

HOLD

Current Price

$4.14

Market Cap

45.0M

Sector

N/A

ML Signal

HOLD

Logo Intercure Ltd.

INCR

Intercure Ltd.

HOLD

Current Price

$0.83

Market Cap

42.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IXHL
INCR
Founded
2001
1994
Country
Australia
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.0M
42.3M
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
IXHL
INCR
Price
$4.14
$0.83
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
502.4K
16.9K
Earning Date
05-14-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$12,000.00
N/A
Revenue This Year
N/A
$69.54
Revenue Next Year
N/A
$41.75
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.11
$0.68
52 Week High
$6.39
$1.77

Technical Indicators

Market Signals
Indicator
IXHL
INCR
Relative Strength Index (RSI) 66.02 63.64
Support Level $0.34 $0.72
Resistance Level $5.17 $0.88
Average True Range (ATR) 0.32 0.04
MACD 0.06 0.01
Stochastic Oscillator 91.82 80.00

Price Performance

Historical Comparison
IXHL
INCR

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

About INCR Intercure Ltd.

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.

Share on Social Networks: